Industry News
You are here: Home » News » Industry News

Latest News & Updates of Loncom Pharma

2026
DATE
11 - 13
China Q3 Guideline for Topical Generics: What Changes
China's CDE issued a new Q3 characterization guideline for topically acting chemical generics on September 30, 2026, covering ten attributes plus sampling requirements and evaluation standards, effective immediately on publication.
Read More
2026
DATE
11 - 13
China Market Exclusivity for Rare Disease & Pediatric Drugs
NMPA proposes market exclusivity for rare disease drugs at seven, five or four years, and for pediatric drugs at two or one year, with comments open until 18 November 2026.
Read More
2026
DATE
10 - 29
China Pharma Plan 2026-2030: Innovation and Global Reach
China published its 15th Five-Year Plan for the pharmaceutical industry on 18 September 2026, setting ten 2030 targets and 25 key tasks on innovation, resilient supply chains and international expansion.
Read More
2026
DATE
10 - 22
ICH M13B Final Guideline: Additional Strength Biowaivers
EMA's final ICH M13B guideline, published 21 September 2026 and effective 17 March 2027, sets the criteria for waiving in vivo bioequivalence studies for additional strengths of immediate-release oral solids.
Read More
  • Total 6 pages  Go to Page
  • Go
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong, China

QUICK LINKS

PRODUCT CATEGORY

Copyright © 2023 Shandong Loncom Pharmaceutical Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy
Supported by leadong.com
Contact Us